Medpace Holdings (MEDP) last issued guidance on February 9, 2026 for fiscal year 2026. The company guided earnings per share in the range of $16.68 - $17.50, compared to a consensus EPS estimate of $15.83. Medpace Holdings also guided revenue in the range of $2.75B - $2.85B for the period.
Compared to prior guidance, Medpace Holdings raised its revenue forecast from a prior range of $2.48B - $2.53B.
Medpace Holdings has issued 18 guidance updates between April 25, 2022 and February 9, 2026. During this period, the company raised its outlook 15 times, reflecting management's growing confidence in business performance.
Review all historical guidance issued by Medpace Holdings, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for Medpace Holdings (MEDP) was reported on February 9, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $16.68 to $17.50, compared to the estimated EPS of $15.83. Additionally, Medpace Holdings forecasted revenue between $2.75B and $2.85B for the period.
Medpace Holdings (MEDP) guided EPS in the range of $16.68 to $17.50 for the fiscal year 2026. The consensus analyst EPS estimate is $15.83.
Medpace Holdings (MEDP) guided revenue in the range of $2.75B to $2.85B for the fiscal year 2026.
Medpace Holdings (MEDP) raised its revenue guidance from a prior range of $2.48B - $2.53B to $2.75B - $2.85B for the fiscal year 2026.
Medpace Holdings (MEDP) last issued guidance on February 9, 2026 for the fiscal year 2026.